A truncated variant of the hepatitis C virus core induces a slow but potent immune response in mice following DNA immunization

被引:16
作者
Dueñas-Carrera, S
Alvarez-Lajonchere, L
Alvarez-Obregón, JC
Herrera, A
Lorenzo, LJ
Pichardo, D
Morales, J
机构
[1] Ctr Ingn Genet & Biotecnol, Vaccine Div, HCV Dept, Havana, Cuba
[2] Ctr Ingn Genet & Biotecnol, Vaccine Div, AIDS Dept, Havana, Cuba
关键词
DNA immunization; HCV core; immune response;
D O I
10.1016/S0264-410X(00)00209-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccination of BALB/c mice with pIDKCo, a plasmid containing the coding sequence for the first 176 amino acids of the hepatitis C virus (HCV) core protein, induced both humoral and cellular specific immune responses. Particularly, the level of anti-core antibodies increased slowly with time up to a mean value above 1:8000 that was generally superior than that found in anti-HCV positive individuals. Six out of nine anti-HCV positive human sera were able to inhibit at different extent the binding of mouse anti-core sera to a recombinant capsid protein. Our results show that it is possible to elicit a potent humoral and cellular immune response against the HCV core antigen in mice following DNA immunization. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:992 / 997
页数:6
相关论文
共 28 条
[1]   LYMPHOCYTE-T RESPONSE TO HEPATITIS-C VIRUS IN DIFFERENT CLINICAL COURSES OF INFECTION [J].
BOTARELLI, P ;
BRUNETTO, MR ;
MINUTELLO, MA ;
CALVO, P ;
UNUTMAZ, D ;
WEINER, AJ ;
CHOO, QL ;
SHUSTER, JR ;
KUO, G ;
BONINO, F ;
HOUGHTON, M ;
ABRIGNANI, S .
GASTROENTEROLOGY, 1993, 104 (02) :580-587
[2]   Limited humoral immunity in hepatitis C virus infection [J].
Chen, M ;
Sällberg, M ;
Sönnerborg, A ;
Weiland, O ;
Mattsson, L ;
Jin, L ;
Birkett, A ;
Peterson, D ;
Milich, DR .
GASTROENTEROLOGY, 1999, 116 (01) :135-143
[3]  
CHEN Z, 1995, VACCINE RES, V4, P135
[4]   DNA vaccines [J].
Donnelly, JJ ;
Ulmer, JB ;
Shiver, JW ;
Liu, MA .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :617-648
[5]  
Duenas-Carrera Santiago, 1999, Biotecnologia Aplicada, V16, P226
[6]  
Encke J, 1998, J IMMUNOL, V161, P4917
[7]   A LONG-TERM STUDY OF HEPATITIS-C VIRUS-REPLICATION IN NON-A, NON-B HEPATITIS [J].
FARCI, P ;
ALTER, HJ ;
WONG, D ;
MILLER, RH ;
SHIH, JW ;
JETT, B ;
PURCELL, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (02) :98-104
[8]   EXPRESSION AND IDENTIFICATION OF HEPATITIS C VIRUS POLYPROTEIN CLEAVAGE PRODUCTS [J].
GRAKOUI, A ;
WYCHOWSKI, C ;
LIN, C ;
FEINSTONE, SM ;
RICE, CM .
JOURNAL OF VIROLOGY, 1993, 67 (03) :1385-1395
[9]   CANCER GENE-THERAPY USING PLASMID DNA - PURIFICATION OF DNA FOR HUMAN CLINICAL-TRIALS [J].
HORN, NA ;
MEEK, JA ;
BUDAHAZI, G ;
MARQUET, M .
HUMAN GENE THERAPY, 1995, 6 (05) :565-573
[10]   MOLECULAR-BIOLOGY OF THE HEPATITIS-C VIRUSES - IMPLICATIONS FOR DIAGNOSIS, DEVELOPMENT AND CONTROL OF VIRAL DISEASE [J].
HOUGHTON, M ;
WEINER, A ;
HAN, J ;
KUO, G ;
CHOO, QL .
HEPATOLOGY, 1991, 14 (02) :381-388